Fig. 12From: The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaPossible molecular mechanism by which erastin inhibits the proliferation and progression of HCC. a The interaction of proteins regulated by erastin. b-c GO analysis (b) and KEGG pathway analysis (c) of the potential targets of erastinBack to article page